. . . . . . . "[The results of the first oral combination of Sofosbuvir and RBV for 12�weeks in genotype 3-infected patients have been rather disappointing with a slightly lower SVR than after 24�weeks of PEG-IFN: around 60%, and only 30% in patients with cirrhosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:35+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .